Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
January 5, 2002
ES cell-mediated conditional transgenesis
M Gertsenstein, C Lobe, A Nagy
Antimicrobial Agents and Chemotherapy
|
October 1, 1989
Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses
M N Ellis, D C Lobe, T Spector
Antiviral Research
|
February 1, 1991
Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice
D C Lobe, T Spector, M N Ellis
Antiviral Research
|
December 24, 1998
Therapeutic evaluation of compounds in the SCID-RA papillomavirus model
D C Lobe, J W Kreider, W C Phelps
Antiviral Chemistry & Chemotherapy
|
January 6, 1999
Molecular targets for human papillomaviruses: prospects for antiviral therapy
W C Phelps, J A Barnes, D C Lobe
Journal of Lipid Research
|
October 23, 2008
The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress
Jodi M Maglich, David C Lobe, John T Moore
Antimicrobial Agents and Chemotherapy
|
May 1, 1992
Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir
T Spector, D C Lobe, M N Ellis, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1986
Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude mice
M N Ellis, J L Martin, D C Lobe, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1987
A serine protease (CCP1) is sequestered in the cytoplasmic granules of cytotoxic T lymphocytes
M J Redmond, M Letellier, J M Parker, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1989
Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1
M N Ellis, R Waters, E L Hill, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
January 5, 2002
ES cell-mediated conditional transgenesis
M Gertsenstein, C Lobe, A Nagy
Antimicrobial Agents and Chemotherapy
|
October 1, 1989
Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses
M N Ellis, D C Lobe, T Spector
Antiviral Research
|
February 1, 1991
Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice
D C Lobe, T Spector, M N Ellis
Antiviral Research
|
December 24, 1998
Therapeutic evaluation of compounds in the SCID-RA papillomavirus model
D C Lobe, J W Kreider, W C Phelps
Antiviral Chemistry & Chemotherapy
|
January 6, 1999
Molecular targets for human papillomaviruses: prospects for antiviral therapy
W C Phelps, J A Barnes, D C Lobe
Journal of Lipid Research
|
October 23, 2008
The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress
Jodi M Maglich, David C Lobe, John T Moore
Antimicrobial Agents and Chemotherapy
|
May 1, 1992
Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir
T Spector, D C Lobe, M N Ellis, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1986
Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude mice
M N Ellis, J L Martin, D C Lobe, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 15, 1987
A serine protease (CCP1) is sequestered in the cytoplasmic granules of cytotoxic T lymphocytes
M J Redmond, M Letellier, J M Parker, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1989
Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1
M N Ellis, R Waters, E L Hill, et al.
Page
of 2